9/23, 12:51 PM (Source: TeleTrader)
more TeleTrader news

J&J starts final phase of COVID-19 vaccine testing

Johnson & Johnson announced on Wednesday that it began a Phase 3 trial for its COVID-19 vaccine which is included in the United States government's Operation Warp Speed.

The company stated that the new trial including 60,000 volunteers from three continents is set to start after previous clinical studies showed the vaccine was safe and provided immunogenicity after a single inoculation.

"We greatly value the collaboration and support from our scientific partners and global health authorities as our global team of experts work tirelessly on the development of the vaccine and scaling up our production capacity with a goal to deliver a vaccine for emergency use authorization in early 2021," Chief Scientific Officer Paul Stoffels stated.

Breaking the News / VP